Cardiatec Raises £1.4M To Tackle Heart Disease With Ai
07/06/22, 2:33 PM
Location
Money raised
£1.4 million
Round Type
seed
Cambridge-based health tech startup CardiaTec has secured a £1.4m pre-seed investment to further develop its AI-driven cardiovascular disease treatment.
Company Info
Location
cambridge, maryland, united states
Additional Info
Founded at the University of Cambridge, CardiaTec is developing a target discovery platform that uses AI to analyse large-scale cardiovascular data. “Despite the prevalence of cardiovascular ailments, there has been significant under-investment, so we believe these funds will provide CardiaTec with the opportunity to unearth treatments that make a real difference to patients.”Other participants in the funding round included Crista Galli Ventures, o2h ventures and Cambridge Enterprise.